Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors
Clinical trial NCT05082701 · TERMINATED
Trial details
- NCT number
- NCT05082701
- Sponsor
- Strata Oncology
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-10-02
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.